References
1 Wang Q, Zhang Y, Wu L, et al. Structural and Functional Basis of
SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020;181(4):894‐904.e9.
doi:10.1016/j.cell.2020.03.045
2 Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized
Patients With Coronavirus Disease 2019 in Wuhan, China [published
online ahead of print, 2020 Apr 10]. JAMA Neurol. 2020;e201127.
doi:10.1001/jamaneurol.2020.1127
3 Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and
gustatory dysfunctions as a clinical presentation of mild-to-moderate
forms of the coronavirus disease (COVID-19): a multicenter European
study [published online ahead of print, 2020 Apr 6]. Eur Arch
Otorhinolaryngol. 2020;1‐11. doi:10.1007/s00405-020-05965-1
4 Moriguchi T, Harii N, Goto J, et al. A first case of
meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect
Dis. 2020;94:55-58. doi:10.1016/j.ijid.2020.03.062
5 Zhu H, Rhee JW, Cheng P, et al. Cardiovascular Complications in
Patients with COVID-19: Consequences of Viral Toxicities and Host Immune
Response. Curr Cardiol Rep. 2020;22(5):32.
doi:10.1007/s11886-020-01292-3
6 Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With
Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
[published online ahead of print, 2020 Mar 25]. JAMA Cardiol.
2020;e200950. doi:10.1001/jamacardio.2020.0950
7 Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal
Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
[published online ahead of print, 2020 Mar 27]. JAMA Cardiol.
2020;e201017. doi:10.1001/jamacardio.2020.1017
8 Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of
coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail.
2020;22(5):911-915. doi:10.1002/ejhf.1828
9 Samuels MA. The brain-heart connection. Circulation.
2007;116(1):77–84. doi:10.1161/CIRCULATIONAHA.106.678995
10 Herring N, Kalla M, Paterson DJ. The autonomic nervous system and
cardiac arrhythmias: current concepts and emerging therapies. Nat Rev
Cardiol. 2019;16(12):707–726. doi:10.1038/s41569-019-0221-2
11 Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138
Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in
Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA.
2020;e201585. doi:10.1001/jama.2020.1585
12 Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, Arrhythmic Risk and
Inflammation: Mind the Gap! [published online ahead of print, 2020 Apr
14]. Circulation. 2020;10.1161/CIRCULATIONAHA.120.047293.
doi:10.1161/CIRCULATIONAHA.120.047293
13 Kurisu S, Kihara Y. Interaction Between Brain and Heart. Circ J.
2016;80(9):1905–1906. doi:10.1253/circj.CJ-16-0737
14 Meyer P, Degrauwe S, Van Delden C, Ghadri JR, Templin C. Typical
takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J.
2020;41(19):1860. doi:10.1093/eurheartj/ehaa306
15 Markus HS, Brainin M. COVID-19 and stroke-A global World Stroke
Organization perspective. Int J Stroke. 2020;15(4):361-364.
doi:10.1177/1747493020923472
16 Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is
associated with an increased disease severity in patients with
Coronavirus Disease 2019 (COVID-19): A pooled analysis of published
literature. Int J Stroke. 2020;15(4):385-389.
doi:10.1177/1747493020921664
17 AHA/ASA Stroke Council Leadership. Temporary Emergency Guidance to US
Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic:
On Behalf of the American Heart Association/American Stroke Association
Stroke Council Leadership. Stroke. 2020;51(6):1910-1912.
doi:10.1161/STROKEAHA.120.030023
18 Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19:
Implications for the Cardiovascular System [published online ahead of
print, 2020 Apr 15]. Circulation.
2020;10.1161/CIRCULATIONAHA.120.047549.
doi:10.1161/CIRCULATIONAHA.120.047549
19 Sörös P, Hachinski V. Cardiovascular and neurological causes of
sudden death after ischaemic stroke. Lancet Neurol. 2012;11(2):179–188.
doi:10.1016/S1474-4422(11)70291-5
20 Scheitz JF, Nolte CH, Doehner W, Hachinski V, Endres M. Stroke-heart
syndrome: clinical presentation and underlying mechanisms. Lancet
Neurol. 2018;17(12):1109–1120. doi:10.1016/S1474-4422(18)30336-3